Don’t miss the latest developments in business and finance.

Board of Sharon Bio-Medicine allots warrants on preferential basis

Image
Capital Market
Last Updated : Oct 20 2014 | 1:32 PM IST

At meeting held on 20 October 2014

Sharon Bio-Medicine announced that the Board of Directors of the Company at its Meeting held on 20 October 2014 has resolved and allotted 1,61,11,000 Warrants to the Promoter group on Preferential basis in compliance of SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2009.

Powered by Capital Market - Live News

More From This Section

First Published: Oct 20 2014 | 12:58 PM IST

Next Story